Jose G Trevino Selected Research

AP23846

9/2006	Antiangiogenic and antitumor effects of SRC inhibition in ovarian carcinoma.
12/2005	AP23846, a novel and highly potent Src family kinase inhibitor, reduces vascular endothelial growth factor and interleukin-8 expression in human solid tumor cell lines and abrogates downstream angiogenic processes.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jose G Trevino Research Topics

Disease

54	Neoplasms (Cancer) 04/2024 - 05/2005
28	Pancreatic Neoplasms (Pancreatic Cancer) 11/2023 - 08/2005
19	Adenocarcinoma 11/2023 - 05/2005
12	Cachexia 12/2023 - 01/2017
7	Neoplasm Metastasis (Metastasis) 01/2023 - 12/2005
4	Carcinogenesis 01/2023 - 10/2019
4	Atrophy 01/2021 - 01/2019
3	Weight Loss (Weight Reduction) 12/2023 - 01/2019
3	Carcinoma (Carcinomatosis) 01/2020 - 09/2006
2	Inflammation (Inflammations) 01/2024 - 05/2020
2	Colorectal Neoplasms (Colorectal Cancer) 10/2023 - 10/2023
2	Peritoneal Neoplasms 06/2022 - 01/2022
2	Infections 01/2022 - 05/2020
2	Pancreatitis 05/2020 - 10/2014
2	Muscular Atrophy (Muscle Atrophy) 11/2019 - 12/2018
2	Pancreatic Fistula (Pancreatic Fistulas) 01/2016 - 10/2014
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 02/2024
1	Lung Neoplasms (Lung Cancer) 02/2024
1	Rectal Neoplasms (Rectal Cancer) 10/2023
1	Colonic Neoplasms (Colon Cancer) 10/2023
1	Appendiceal Neoplasms (Appendix Cancer) 08/2023
1	Dysbiosis 11/2022
1	Sarcopenia 06/2022
1	Obesity 06/2022
1	Endometrial Neoplasms (Endometrial Cancer) 01/2022
1	Cholecystitis 01/2021
1	Cholangitis 01/2021
1	Abdominal Pain (Pain, Abdominal) 05/2020
1	Hemolytic Anemia 05/2020
1	Thrombocytopenia (Thrombopenia) 05/2020

Drug/Important Bio-Agent (IBA)

9	Proteins (Proteins, Gene)FDA Link 02/2024 - 10/2005
8	Gemcitabine FDA Link 01/2022 - 07/2006
8	Interleukin-8 (Interleukin 8)IBA 02/2020 - 08/2005
7	CytokinesIBA 11/2022 - 01/2017
5	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 09/2006 - 08/2005
4	Biomarkers (Surrogate Marker)IBA 04/2024 - 09/2015
4	Phosphotransferases (Kinase)IBA 01/2019 - 10/2005
3	src-Family KinasesIBA 10/2021 - 10/2005
3	Conditioned Culture MediaIBA 11/2019 - 08/2005
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 12/2005 - 05/2005
2	CollagenIBA 04/2024 - 07/2018
2	EnzymesIBA 01/2024 - 01/2018
2	RNA (Ribonucleic Acid)IBA 12/2023 - 01/2022
2	PrebioticsIBA 11/2022 - 12/2019
2	Dasatinib (BMS 354825)FDA Link 10/2021 - 03/2006
2	Complement System Proteins (Complement)IBA 01/2021 - 05/2020
2	MEF2 Transcription FactorsIBA 01/2021 - 01/2020
2	Hemoglobins (Hemoglobin)IBA 05/2020 - 01/2017
2	Nicotine FDA Link 02/2020 - 04/2016
2	Antineoplastic Agents (Antineoplastics)IBA 10/2019 - 01/2019
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2019 - 04/2016
2	Glucose (Dextrose)FDA LinkGeneric 01/2018 - 05/2016
2	Interleukin-6 (Interleukin 6)IBA 01/2017 - 01/2017
2	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 05/2016 - 09/2015
2	Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA 04/2016 - 09/2015
2	LigandsIBA 12/2015 - 09/2015
2	AP23846IBA 09/2006 - 12/2005
2	Adenosine Triphosphate (ATP)IBA 06/2006 - 12/2005
2	Small Interfering RNA (siRNA)IBA 03/2006 - 05/2005
1	MethyltransferasesIBA 02/2024
1	Peptides (Polypeptides)IBA 02/2024
1	Arginine (L-Arginine)FDA Link 02/2024
1	ImmunosorbentsIBA 01/2024
1	Interleukin-2 (IL2)IBA 01/2024
1	Double-Stranded RNA (RNA, Double Stranded)IBA 11/2023
1	Poly CIBA 11/2023
1	3-methylfentanyl isothiocyanateIBA 12/2022
1	snake venom protein C activatorIBA 01/2022
1	Annexin A5IBA 01/2022
1	Toll-Like Receptor 4IBA 01/2022
1	Calmodulin (Calcium-Dependent Activator Protein)IBA 01/2022
1	Immunoglobulin D (IgD)IBA 01/2022
1	CalciumIBA 01/2022
1	Calcium Channel Blockers (Blockers, Calcium Channel)IBA 01/2022
1	DT2216IBA 01/2022
1	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2022
1	Proteolysis Targeting ChimeraIBA 01/2022
1	VaccinesIBA 01/2022
1	Fluorouracil (Carac)FDA LinkGeneric 10/2021
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 10/2021
1	AntibodiesIBA 01/2021
1	130-nm albumin-bound paclitaxelIBA 01/2021
1	Caveolin 1IBA 01/2021
1	Histone Deacetylases (Histone Deacetylase)IBA 01/2021
1	trichostatin A (A 300)IBA 01/2021
1	HaptoglobinsIBA 05/2020
1	Lipase (Acid Lipase)FDA Link 05/2020

Therapy/Procedure

25	Therapeutics 04/2024 - 10/2005
5	Drug Therapy (Chemotherapy) 01/2022 - 07/2014
5	Immunotherapy 01/2022 - 12/2018
3	Minimally Invasive Surgical Procedures 10/2023 - 01/2022
3	Hyperthermic Intraperitoneal Chemotherapy 08/2023 - 01/2022
3	Cytoreduction Surgical Procedures 08/2023 - 01/2022
3	Pancreaticoduodenectomy 01/2023 - 01/2016
3	Neoadjuvant Therapy 10/2022 - 10/2015
3	Precision Medicine 01/2022 - 12/2018
2	Contraindications 06/2022 - 01/2016
1	Patient Readmission 10/2023
1	Aftercare (After-Treatment) 01/2022
1	Stents 01/2021